KLRS - Allovir, Inc.
9.82
0.145 1.477%
Share volume: 41,326
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$9.68
0.14
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-09-2024 | 11-12-2024 | 03-07-2025 | 05-14-2025 | 11-12-2025 | |
| Cash flow financing | 0.000 | 21.000 K | 0.000 | 0.000 | 107.267 M | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 99.767 M | 0.000 | |
| Cash flow | -4.380 M | 18.702 M | 0.000 | 0.000 | 99.826 M | 0.000 | |
| Net income | -30.299 M | -6.076 M | -4.126 M | -18.268 M | -10.196 M | -11.894 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 40.000 M | 30.000 M | 20.000 M | 5.000 M | 0.000 | -34.706 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -4.380 M | 18.702 M | 11.561 M | 1.433 M | 99.826 M | -46.039 M |